SBI has been focused on protecting inventions in European Patent Office(EPO) with three publications in Q2 2024

The European Patent Office(EPO) Patent Office dominates the patent grants with nearly 50% of grants. The United States(US), European Patent Office(EPO), Brazil(BR), and Japan(JP) patent Office are among the top ten patent offices where SBI is filings its patents. Among the top granted patent authorities, SBI has 50% of its grants in European Patent Office(EPO), 25% in Brazil(BR) and 25% in Japan(JP).

Roche could be the strongest competitor for SBI

Patents related to cell & gene therapy and rare diseases lead SBI's portfolio

SBI has the highest number of patents in cell & gene therapy followed by, rare diseases. For cell & gene therapy no patents were filed and 20% of patents were granted in Q2 2024.

Depression related patents lead SBI portfolio

SBI has highest number of patents in depression.

For comprehensive analysis of SBI's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

Be better informed